Vernal’s Growth Since 2021
Seven Days wrote a great follow up article on Vernal’s growth since the summer of 2021. Click the link below to see what we’ve been up to. What a difference a year makes! New Companies Are Riding Vermont’s Health Tech…
News
Meet Vernal’s Experts at mRNA Health Conference
Vernal is proud to be the Silver Sponsor for this exciting event! Connect with one of Vernal’s experts on November 8-10, 2022 in Boston and meet them at our booth. We want to know about your mRNA and LNP projects,…
Vernal Starts Construction on Vermont mRNA Facility
Vernal Biosciences is excited to announce the start of construction on its new, 23,000 square foot mRNA manufacturing facility in Essex Junction, Vt. The new facility will include state-of-the-art equipment and clean rooms to support clinical mRNA and LNP mRNA…
A Larger Facility
Local NBC affiliate NBC5 came to visit Vernal Bioscience to discuss the eventual move to a new, larger facility in Essex and our plans to nearly quadruple our workforce. Watch the story on NBC5.
Vermont Startup Secures $21M for mRNA
Vernal produces high-purity mRNA to supply to companies that develop mRNA-based health treatments. Read the full story at VTDigger.
Colchester’s Vernal Biosciences Raises $20 Million to Expand
Vernal Biosciences has received $21 million from investors and is expanding to a new laboratory in Essex next year.
Burlington Tech Startup Raises Funds for Growth
Vernal Biosciences has raised $21 million to build a manufacturing facility in Essex that will scale up the business from supporting research to being involved in clinical trials.
Vernal Biosciences Raises $21M for mRNA Growth
Vernal Biosciences announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solutions.
Vernal welcomes Scott Vanson and JJ Bivona to the team
We are excited to announce the addition of two new members to the Vernal team: Scott Vanson, Ph.D. and JJ Bivona, Ph.D.
Vernal Biosciences awarded nearly $100k in Vermont Training Grant
Vernal Biosciences has been awarded a $99,475 grant from the Vermont Training Program (VTP).
Vernal Launches Preclinical LNP Formulation Service
We recently completed a biodistribution study of lipid nanoparticles containing mRNA encoding luciferase in mice.
Vernal to Expand mRNA Team Threefold
Vernal Biosciences, the Colchester-based manufacturer of mRNA used in cutting-edge medicines, plans to nearly triple the size of its staff, from 12 to 35, using a grant from the Vermont Training Program. Read the full story here.